Tetrahydroaminocrine en es it fr

Tetrahydroaminocrine Brand names, Tetrahydroaminocrine Analogs

Tetrahydroaminocrine Brand Names Mixture

  • No information avaliable

Tetrahydroaminocrine Chemical_Formula


Tetrahydroaminocrine RX_link


Tetrahydroaminocrine fda sheet

Tetrahydroaminocrine msds (material safety sheet)

Tetrahydroaminocrine MSDS

Tetrahydroaminocrine Synthesis Reference

No information avaliable

Tetrahydroaminocrine Molecular Weight

198.264 g/mol

Tetrahydroaminocrine Melting Point

183.5 oC

Tetrahydroaminocrine H2O Solubility

217 mg/L

Tetrahydroaminocrine State


Tetrahydroaminocrine LogP


Tetrahydroaminocrine Dosage Forms

No information avaliable

Tetrahydroaminocrine Indication

For the treatment of mild to moderate dementia of the Alzheimer's type.

Tetrahydroaminocrine Pharmacology

Tacrine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. Tacrine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Tacrine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, tacrine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. There is no evidence that tacrine alters the course of the underlying dementing process.

Tetrahydroaminocrine Absorption

Tacrine is rapidly absorbed. Absolute bioavailability of tacrine is approximately 17 ± 13%.

Tetrahydroaminocrine side effects and Toxicity

No information avaliable

Tetrahydroaminocrine Patient Information

No information avaliable

Tetrahydroaminocrine Organisms Affected

Humans and other mammals